# EDGAR Filing Document

**Accession Number:** 0001839558
**File Stem:** 0001562180-23-001612
**Filing Date:** 2023-2
**Character Count:** 7449
**Document Hash:** 85cf9ca074d30ae5f7add03c60c1690b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001562180-23-001612.hdr.sgml**: 20230222

**ACCESSION NUMBER**: 0001562180-23-001612

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230221

**FILED AS OF DATE**: 20230222

**DATE AS OF CHANGE**: 20230222

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Thomson Andrew Justin Mackenzie
- **CENTRAL INDEX KEY:** 0001839558

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-32191
- **FILM NUMBER:** 23650951

**MAIL ADDRESS:**
- **STREET 1:** 100 E. PRATT STREET
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21202
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PRICE T ROWE GROUP INC
- **CENTRAL INDEX KEY:** 0001113169
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
- **IRS NUMBER:** 522264646
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 100 EAST PRATT STREET
- **STREET 2:** P.O. BOX 89000
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21289-0320
- **BUSINESS PHONE:** 4103452000

**MAIL ADDRESS:**
- **STREET 1:** 100 EAST PRATT STREET
- **STREET 2:** P.O. BOX 89000
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21289-0320

## Ex-24

```

LIMITED POWER OF ATTORNEY

	THE UNDERSIGNED, Andrew Justin Mackenzie Thomson, hereby
constitutes and appoints, with full power of substitution, the Chief
Executive Officer, the Chairman, the Vice Chairman, the Chief
Financial Officer, the Director of Corporate Services, the Secretary
or Assistant Secretary of the Corporation of T. Rowe Price Group, Inc.
(the "Corporation"), the true and lawful attorney-in-fact of the
undersigned, with full power and authority in the name of and for and
on behalf of the undersigned to execute and file any Form 4 or Form 5
for the purpose of reporting securities transactions to the Securities
and Exchange Commission under Section 16 of the Securities Exchange
Act of 1934, as amended.

This Power of Attorney is made under, and shall be governed pursuant
to, the laws of the State of Maryland.

Date:  1/5/2021

/s/Andrew Justin Mackenzie Thomson
Andrew Justin Mackenzie Thomson

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Thomson Andrew Justin Mackenzie<br><sub>(Last) (First) (Middle)</sub><br>100 E. PRATT STREET<br><sub>(Street)</sub><br>BALTIMORE, MD 21202<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-02-21 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Vice President_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>PRICE T ROWE GROUP INC [ TROW ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2023-02-21 |  | M |  | 11969.00 | A | $68.6074 | 141405.00 | D |  |
| Common Stock | 2023-02-21 |  | S |  | 7069.00 | D | 114.092<sup>(1)</sup> | 134336.00 | D |  |
| Common Stock | 2023-02-21 |  | S |  | 4900.00 | D | 115.1495<sup>(2)</sup> | 129436.00 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Option | $68.6074 | 2023-02-21 |  | M |  |  | 11969.00 | <sup>(3)</sup> | 2023-02-21 | Common Stock | 11969.00 | $0.00 | 0.00 | D |  |

---

### Footnotes:

(1) The range of prices for this transaction were $114.00 to $114.20.  Will provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

(2) The range of prices for this transaction were $115.00 to $115.26.  Will provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

(3) 02/21/2013 Grant - The option vests 20% annually over a 5 year period beginning on 12/10/2014.

**Signature:** Cheryl L. Emory, Assistant Corporate Secretary, as attorney in fact for Thomson, Andrew Justin Mackenzie  
**Date:** 2023-02-22

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**